| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00079521 |
Purpose
This study will evaluate the effectiveness of therapeutic touch in treating wrist fractures in women past menopause.
| Condition | Intervention | Phase |
|
Osteoporosis Fractures |
Procedure: Therapeutic Touch |
Phase II |
| MedlinePlus related topics: | Fractures Osteoporosis |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Efficacy Study |
| Official Title: | The Effect of Therapeutic Touch on Bone Formation in Postmenopausal Women After Wrist Fracture |
| Estimated Enrollment: | 125 |
| Study Start Date: | March 2003 |
| Estimated Study Completion Date: | April 2006 |
In the United States, the use of complementary and alternative medicine (CAM) increased by approximately 25% between 1990 and 1997. The number of visits to CAM practitioners exceeded visits to primary care physicians by about 250 million in 1997. Energy medicine modalities, including therapeutic touch, healing touch, and reiki, are commonly utilized for conditions ranging from headache to cancer, yet understanding of the human energy field and how it may be used in healing is limited. This study will examine the effect of therapeutic touch on fracture healing in postmenopausal women.
Women will be enrolled in the study within one week of a wrist fracture and will receive either therapeutic touch or a sham (placebo) treatment daily for 3 weeks. Assessments will include blood and urine analysis and measures of pain and function in the affected wrist.
Eligibility
| Ages Eligible for Study: | 40 Years to 85 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criertia:
Contacts and Locations| United States, Connecticut | |||||
| University of Connecticut Health Center | |||||
| Farmington, Connecticut, United States, 06030-5215 | |||||
| Principal Investigator: | Karen M. Prestwood, MD | University of Connecticut |
More Information
| Study ID Numbers: | P20 AT000756-01P1 |
| First Received: | March 9, 2004 |
| Last Updated: | August 16, 2006 |
| ClinicalTrials.gov Identifier: | NCT00079521 |
| Health Authority: | United States: Federal Government |
|
|
|
|
